Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: Implications for early treatment of Alzheimer's disease
- 1 September 1997
- journal article
- Published by Wiley in Journal of Neurobiology
- Vol. 33 (3) , 329-342
- https://doi.org/10.1002/(sici)1097-4695(199709)33:3<329::aid-neu10>3.0.co;2-a
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- A femtomolar-acting neuroprotective peptide.Journal of Clinical Investigation, 1996
- Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's diseaseNeurology, 1995
- PACAP Functions as a Neurotrophic FactoraAnnals of the New York Academy of Sciences, 1994
- Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors.Proceedings of the National Academy of Sciences, 1994
- Dementia of the alzheimer type: Effects on the spontaneous EEG described by dipole sourcesPsychiatry Research: Neuroimaging, 1993
- Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell culturesMolecular Brain Research, 1991
- Vasoactive intestinal peptide and electrical activity influence neuronal survival.Proceedings of the National Academy of Sciences, 1986
- Neurotrophic action of VIP on spinal cord culturesPeptides, 1985
- Behavioural actions of vasoactive intestinal peptide (VIP)Neuropeptides, 1984
- Postnatal development of locomotion in the laboratory ratAnimal Behaviour, 1975